Innovative digital treatment aims to improve quality of life for cancer survivors

The SEAMLESS Study, a clinical trial for cancer survivors, is set to investigate the effectiveness of Mobio Interactive’s mobile programme, Mindfulness-Based Cancer Survivorship (MBCS), in reducing post-treatment side-effects for cancer survivors across Canada. The study aims to enhance the psychosocial care available to survivors through the use of a low-cost, evidence-based intervention delivered remotely via the digital theragnostic platform, AmDTx.

OBIO® through its Early Adopter Health Network (EAHN™) is supporting a new CHEO Research Institute study, in collaboration with Mobio Interactive to examine the feasibility of delivering clinically validated mindfulness therapy for youth through the latter's AI-powered mobile app. Read more about the partnership here.